ArticleFrontiers in microbiology2021
Prevalence and Characteristics of Ceftriaxone-Resistant
Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 23 citations in OpenAlex.
- Drinking Water Supplementation ofMicroorganisms · 2025Article
- Evolutionary adaptations of a pediatric pathogen: low-inflammatory and high-resistance phenotypes in the emergingMicrobiology spectrum · 2025Article
- Resistance, virulence and genetic diversity of Salmonella Typhimurium in South Africa (1999-2021).The Onderstepoort journal of veterinary research · 2025Article
- A Six-Year Investigation of the Emergence and Spread of Human Multidrug-Resistant Salmonella enterica Serovar Enteritidis in Tunisia.Current microbiology · 2025Article
- A systematic review of recent outbreaks and the efficacy and safety of drugs approved for the treatment ofIJID regions · 2025Review
- AI-2 Signaling: A Potential Driver of Bacteremia in Non-TyphoidalInfection and drug resistance · 2025Article
- Genomic epidemiology of ceftriaxone-resistant non-typhoidal Salmonella enterica strain in China.BMC genomics · 2024Article
- Plasmid-mediated azithromycin resistance in non-typhoidal Salmonella recovered from human infections.The Journal of antimicrobial chemotherapy · 2024Article
- Prevalence, Serotypes and Antimicrobial Resistance ofInfection and drug resistance · 2024Article
- Plasmid Composition, Antimicrobial Resistance and Virulence Genes Profiles of Ciprofloxacin- and Third-Generation Cephalosporin-Resistant FoodborneMicroorganisms · 2023Article
- The Genetic Characteristics and Carbapenem Resistance Mechanism of ST307Antibiotics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The non-Typhi
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.